These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2127603)

  • 41. Comparison of human menopausal gonadotropin, clomiphene citrate, and combined human menopausal gonadotropin-clomiphene citrate stimulation protocols for in vitro fertilization.
    Diamond MP; Hill GA; Webster BW; Herbert CM; Rogers BJ; Osteen KG; Maxson WS; Vaughn WK; Wentz AC
    Fertil Steril; 1986 Dec; 46(6):1108-12. PubMed ID: 2946610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Follicular stimulation for in vitro fertilization using pituitary suppression and human menopausal gonadotropins.
    Awadalla SG; Friedman CI; Chin NW; Dodds W; Park JM; Kim MH
    Fertil Steril; 1987 Nov; 48(5):811-5. PubMed ID: 3117593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro fertilisation. A review of drug therapy and clinical management.
    Jennings JC; Moreland K; Peterson CM
    Drugs; 1996 Sep; 52(3):313-43. PubMed ID: 8875126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hormonal stimulation for in vitro fertilization: a comparison of fertilization rates and cytogenetic findings in unfertilized oocytes.
    De Sutter P; Dhont M; Vandekerckhove D
    J Assist Reprod Genet; 1992 Jun; 9(3):254-8. PubMed ID: 1525457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of short pituitary suppression with gonadotropin-releasing hormone agonist leuprolide during induction of ovulation for in vitro fertilization.
    Henig I; Chan PJ; Prough SG; Tredway DR
    J In Vitro Fert Embryo Transf; 1989 Aug; 6(4):195-200. PubMed ID: 2515234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF/ICSI cycles.
    Lin YH; Seow KM; Hsieh BC; Huang LW; Chen HJ; Huang SC; Chen CY; Chen PH; Hwang JL; Tzeng CR
    J Assist Reprod Genet; 2007 Aug; 24(8):331-6. PubMed ID: 17636445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The evaluation of a new 7-day gonadotropin-releasing hormone agonist protocol in the controlled ovarian hyperstimulation for in vitro fertilization.
    Yang TS; Tsan SH; Wang BC; Chang SP; Ng HT
    J Obstet Gynaecol Res; 1996 Apr; 22(2):133-7. PubMed ID: 8697342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Good results of milder form of ovarian stimulation in an in vitro fertilization/intracytoplasmic sperm injection program.
    Grochowski D; Wołczyński S; Kuczyński W; Domitrz J; Szamatowicz J; Szamatowicz M
    Gynecol Endocrinol; 1999 Oct; 13(5):297-304. PubMed ID: 10599545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
    Garcia JE; Padilla SL; Bayati J; Baramki TA
    Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GnRH antagonist improved blastocyst quality and pregnancy outcome after multiple failures of IVF/ICSI-ET with a GnRH agonist protocol.
    Takahashi K; Mukaida T; Tomiyama T; Goto T; Oka C
    J Assist Reprod Genet; 2004 Sep; 21(9):317-22. PubMed ID: 15587144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
    Dahan MH; Agdi M; Shehata F; Son W; Tan SL
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunosuppressive activity in human embryo growth media is associated with successful pregnancy: effect of gonadotropin releasing hormone agonist (GnRHa) treatment of patients undergoing in vitro fertilization and embryo transfer (IVF-ET).
    Bose R; Mahadevan MM
    J Clin Immunol; 1990 May; 10(3):175-81. PubMed ID: 2114421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exogenous gonadotropin requirements are increased in leuprolide suppressed women undergoing ovarian stimulation.
    Horvath PM; Styler M; Hammond JM; Shelden RM; Kemmann E
    Fertil Steril; 1988 Jan; 49(1):159-62. PubMed ID: 3121396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relative success of gonadotropin-releasing hormone analogue, clomiphene citrate, and gonadotropin in 1,099 cycles of in vitro fertilization.
    Dor J; Ben-Shlomo I; Levran D; Rudak E; Yunish M; Mashiach S
    Fertil Steril; 1992 Nov; 58(5):986-90. PubMed ID: 1426387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer.
    Dumesic DA; Lesnick TG; Stassart JP; Ball GD; Wong A; Abbott DH
    Fertil Steril; 2009 Jul; 92(1):217-21. PubMed ID: 18675414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of varying stages of endometriosis on the outcome of in vitro fertilization-embryo transfer.
    Pal L; Shifren JL; Isaacson KB; Chang Y; Leykin L; Toth TL
    J Assist Reprod Genet; 1998 Jan; 15(1):27-31. PubMed ID: 9493063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Controlled ovarian hyperstimulation for in vitro fertilization using buserelin and gonadotropin in patients with previous failed cycles.
    Loong EP; Tam PP; Chiu TT; Chan MY; Panesar NS; Lau J
    Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):297-300. PubMed ID: 2129187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GnRH antagonist in older IVF patients. Retrieval rates and clinical outcome.
    Chang PL; Zeitoun KM; Chan LK; Thornton MH; Sauer MV
    J Reprod Med; 2002 Apr; 47(4):253-8. PubMed ID: 12012875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ovarian hyperstimulation for in vitro fertilization preceded by prolonged administration of a gonadotropin-releasing hormone agonist.
    Tanbo T; Dale PO; Abyholm T
    Acta Obstet Gynecol Scand; 1990; 69(4):333-7. PubMed ID: 2123069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.